Varespladib (LY315920), a specific and effective human non-pancreatic secretory phospholipase A2 (hnsPLA) inhibitor(IC50=7 nM), has been investigated for the treatment and prevention of sickle cell disease, vaso-occlusive crisis, and acute coronary syndrome.
Molecular Weight:
380.39
Purity:
97.02%
CAS Number:
[172732-68-2]
Formula:
C21H20N2O5
Target:
Phospholipase
T2044
* VAT and and shipping costs not included. Errors and price changes excepted